ARTICLE | Company News
OsteoArthritis deal
June 6, 1994 7:00 AM UTC
OsteoArthritis entered into its first corporate deal, a five-year agreement with Kaken Pharmaceutical Co. Ltd. (Japan) to develop and market inhibitors of certain cartilage-degrading enzymes involved ...